nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2A6—prostate cancer	0.216	0.465	CbGaD
Pentobarbital—CYP2C19—prostate cancer	0.152	0.327	CbGaD
Pentobarbital—CYP3A4—prostate cancer	0.0967	0.208	CbGaD
Pentobarbital—CYP2C19—Nilutamide—prostate cancer	0.0421	0.126	CbGbCtD
Pentobarbital—CYP2C19—Bicalutamide—prostate cancer	0.0421	0.126	CbGbCtD
Pentobarbital—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0388	0.116	CbGbCtD
Pentobarbital—CYP2C19—Flutamide—prostate cancer	0.0349	0.105	CbGbCtD
Pentobarbital—CYP3A4—Bicalutamide—prostate cancer	0.0204	0.061	CbGbCtD
Pentobarbital—CYP3A4—Estramustine—prostate cancer	0.0189	0.0567	CbGbCtD
Pentobarbital—CYP3A4—Abiraterone—prostate cancer	0.0169	0.0506	CbGbCtD
Pentobarbital—CYP3A4—Flutamide—prostate cancer	0.0169	0.0506	CbGbCtD
Pentobarbital—CYP2C19—Estradiol—prostate cancer	0.0145	0.0434	CbGbCtD
Pentobarbital—CYP3A4—Cabazitaxel—prostate cancer	0.0125	0.0374	CbGbCtD
Pentobarbital—CYP2C19—Prednisone—prostate cancer	0.0125	0.0374	CbGbCtD
Pentobarbital—CYP3A4—Estrone—prostate cancer	0.0122	0.0366	CbGbCtD
Pentobarbital—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0109	0.0326	CbGbCtD
Pentobarbital—CYP3A4—Conjugated Estrogens—prostate cancer	0.00798	0.0239	CbGbCtD
Pentobarbital—CYP3A4—Mitoxantrone—prostate cancer	0.00726	0.0217	CbGbCtD
Pentobarbital—CYP3A4—Estradiol—prostate cancer	0.00701	0.021	CbGbCtD
Pentobarbital—CYP3A4—Prednisone—prostate cancer	0.00603	0.0181	CbGbCtD
Pentobarbital—CYP3A4—Etoposide—prostate cancer	0.00458	0.0137	CbGbCtD
Pentobarbital—CYP3A4—Docetaxel—prostate cancer	0.00419	0.0125	CbGbCtD
Pentobarbital—CYP3A4—Doxorubicin—prostate cancer	0.00312	0.00935	CbGbCtD
Pentobarbital—Rash—Estrone—prostate cancer	0.000465	0.0046	CcSEcCtD
Pentobarbital—Dermatitis—Estrone—prostate cancer	0.000464	0.0046	CcSEcCtD
Pentobarbital—Headache—Estrone—prostate cancer	0.000462	0.00457	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Capecitabine—prostate cancer	0.00046	0.00456	CcSEcCtD
Pentobarbital—Nausea—Estramustine—prostate cancer	0.000458	0.00454	CcSEcCtD
Pentobarbital—Body temperature increased—Cabazitaxel—prostate cancer	0.000456	0.00451	CcSEcCtD
Pentobarbital—Dizziness—Nilutamide—prostate cancer	0.000453	0.00448	CcSEcCtD
Pentobarbital—Dizziness—Flutamide—prostate cancer	0.000451	0.00446	CcSEcCtD
Pentobarbital—Hypersensitivity—Degarelix—prostate cancer	0.000451	0.00446	CcSEcCtD
Pentobarbital—Somnolence—Bicalutamide—prostate cancer	0.000439	0.00435	CcSEcCtD
Pentobarbital—Nausea—Estrone—prostate cancer	0.000438	0.00434	CcSEcCtD
Pentobarbital—Vomiting—Nilutamide—prostate cancer	0.000435	0.00431	CcSEcCtD
Pentobarbital—Anxiety—Ethinyl Estradiol—prostate cancer	0.000434	0.0043	CcSEcCtD
Pentobarbital—Vomiting—Flutamide—prostate cancer	0.000433	0.00429	CcSEcCtD
Pentobarbital—Rash—Nilutamide—prostate cancer	0.000432	0.00428	CcSEcCtD
Pentobarbital—Dermatitis—Nilutamide—prostate cancer	0.000431	0.00427	CcSEcCtD
Pentobarbital—Rash—Flutamide—prostate cancer	0.00043	0.00426	CcSEcCtD
Pentobarbital—Dermatitis—Flutamide—prostate cancer	0.000429	0.00425	CcSEcCtD
Pentobarbital—Headache—Nilutamide—prostate cancer	0.000429	0.00425	CcSEcCtD
Pentobarbital—Headache—Flutamide—prostate cancer	0.000427	0.00423	CcSEcCtD
Pentobarbital—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000425	0.00421	CcSEcCtD
Pentobarbital—Hypersensitivity—Cabazitaxel—prostate cancer	0.000425	0.0042	CcSEcCtD
Pentobarbital—Constipation—Bicalutamide—prostate cancer	0.000423	0.00419	CcSEcCtD
Pentobarbital—Tension—Goserelin—prostate cancer	0.000413	0.00409	CcSEcCtD
Pentobarbital—Tension—Conjugated Estrogens—prostate cancer	0.00041	0.00406	CcSEcCtD
Pentobarbital—Nervousness—Goserelin—prostate cancer	0.000409	0.00405	CcSEcCtD
Pentobarbital—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000409	0.00405	CcSEcCtD
Pentobarbital—Feeling abnormal—Bicalutamide—prostate cancer	0.000407	0.00403	CcSEcCtD
Pentobarbital—Nausea—Nilutamide—prostate cancer	0.000407	0.00403	CcSEcCtD
Pentobarbital—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000406	0.00402	CcSEcCtD
Pentobarbital—Nervousness—Conjugated Estrogens—prostate cancer	0.000405	0.00401	CcSEcCtD
Pentobarbital—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000405	0.00401	CcSEcCtD
Pentobarbital—Nausea—Flutamide—prostate cancer	0.000405	0.00401	CcSEcCtD
Pentobarbital—Dizziness—Degarelix—prostate cancer	0.000405	0.00401	CcSEcCtD
Pentobarbital—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000403	0.00399	CcSEcCtD
Pentobarbital—Liver injury—Epirubicin—prostate cancer	0.000395	0.00391	CcSEcCtD
Pentobarbital—Body temperature increased—Bicalutamide—prostate cancer	0.000391	0.00387	CcSEcCtD
Pentobarbital—Vomiting—Degarelix—prostate cancer	0.000389	0.00385	CcSEcCtD
Pentobarbital—Rash—Degarelix—prostate cancer	0.000386	0.00382	CcSEcCtD
Pentobarbital—Dermatitis—Degarelix—prostate cancer	0.000385	0.00382	CcSEcCtD
Pentobarbital—Headache—Degarelix—prostate cancer	0.000383	0.00379	CcSEcCtD
Pentobarbital—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000382	0.00378	CcSEcCtD
Pentobarbital—Angioedema—Conjugated Estrogens—prostate cancer	0.000381	0.00378	CcSEcCtD
Pentobarbital—Dizziness—Cabazitaxel—prostate cancer	0.000381	0.00377	CcSEcCtD
Pentobarbital—Syncope—Conjugated Estrogens—prostate cancer	0.000374	0.00371	CcSEcCtD
Pentobarbital—Hyperkinesia—Prednisone—prostate cancer	0.00037	0.00367	CcSEcCtD
Pentobarbital—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.000367	0.00363	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Capecitabine—prostate cancer	0.000367	0.00363	CcSEcCtD
Pentobarbital—Vomiting—Cabazitaxel—prostate cancer	0.000366	0.00363	CcSEcCtD
Pentobarbital—Liver injury—Doxorubicin—prostate cancer	0.000365	0.00361	CcSEcCtD
Pentobarbital—Hypersensitivity—Bicalutamide—prostate cancer	0.000364	0.00361	CcSEcCtD
Pentobarbital—Bradycardia—Mitoxantrone—prostate cancer	0.000364	0.0036	CcSEcCtD
Pentobarbital—Nausea—Degarelix—prostate cancer	0.000363	0.0036	CcSEcCtD
Pentobarbital—Headache—Cabazitaxel—prostate cancer	0.000361	0.00357	CcSEcCtD
Pentobarbital—Anxiety—Goserelin—prostate cancer	0.000357	0.00354	CcSEcCtD
Pentobarbital—Constipation—Ethinyl Estradiol—prostate cancer	0.000357	0.00354	CcSEcCtD
Pentobarbital—Anxiety—Conjugated Estrogens—prostate cancer	0.000354	0.00351	CcSEcCtD
Pentobarbital—Confusional state—Goserelin—prostate cancer	0.000347	0.00343	CcSEcCtD
Pentobarbital—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000344	0.00341	CcSEcCtD
Pentobarbital—Nausea—Cabazitaxel—prostate cancer	0.000342	0.00339	CcSEcCtD
Pentobarbital—Shock—Goserelin—prostate cancer	0.000338	0.00335	CcSEcCtD
Pentobarbital—Ataxia—Docetaxel—prostate cancer	0.000336	0.00333	CcSEcCtD
Pentobarbital—Shock—Conjugated Estrogens—prostate cancer	0.000335	0.00332	CcSEcCtD
Pentobarbital—Amobarbital—CYP2A6—prostate cancer	0.000333	0.146	CrCbGaD
Pentobarbital—Hepatocellular injury—Epirubicin—prostate cancer	0.000332	0.00329	CcSEcCtD
Pentobarbital—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00033	0.00327	CcSEcCtD
Pentobarbital—Injection site reaction—Epirubicin—prostate cancer	0.00033	0.00327	CcSEcCtD
Pentobarbital—Phenobarbital—CYP2C18—prostate cancer	0.000329	0.144	CrCbGaD
Pentobarbital—Tension—Estradiol—prostate cancer	0.000328	0.00325	CcSEcCtD
Pentobarbital—Dizziness—Bicalutamide—prostate cancer	0.000327	0.00324	CcSEcCtD
Pentobarbital—Ataxia—Capecitabine—prostate cancer	0.000325	0.00322	CcSEcCtD
Pentobarbital—Nervousness—Estradiol—prostate cancer	0.000324	0.00321	CcSEcCtD
Pentobarbital—Hypotension—Goserelin—prostate cancer	0.000321	0.00318	CcSEcCtD
Pentobarbital—Hypotension—Conjugated Estrogens—prostate cancer	0.000318	0.00315	CcSEcCtD
Pentobarbital—Vomiting—Bicalutamide—prostate cancer	0.000314	0.00311	CcSEcCtD
Pentobarbital—Rash—Bicalutamide—prostate cancer	0.000312	0.00309	CcSEcCtD
Pentobarbital—Dermatitis—Bicalutamide—prostate cancer	0.000311	0.00308	CcSEcCtD
Pentobarbital—Headache—Bicalutamide—prostate cancer	0.00031	0.00307	CcSEcCtD
Pentobarbital—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000308	0.00305	CcSEcCtD
Pentobarbital—Hepatocellular injury—Doxorubicin—prostate cancer	0.000307	0.00304	CcSEcCtD
Pentobarbital—Agitation—Estradiol—prostate cancer	0.000307	0.00304	CcSEcCtD
Pentobarbital—Somnolence—Goserelin—prostate cancer	0.000306	0.00303	CcSEcCtD
Pentobarbital—Injection site reaction—Doxorubicin—prostate cancer	0.000305	0.00302	CcSEcCtD
Pentobarbital—Angioedema—Estradiol—prostate cancer	0.000305	0.00302	CcSEcCtD
Pentobarbital—Somnolence—Conjugated Estrogens—prostate cancer	0.000303	0.003	CcSEcCtD
Pentobarbital—Syncope—Estradiol—prostate cancer	0.0003	0.00297	CcSEcCtD
Pentobarbital—Constipation—Goserelin—prostate cancer	0.000294	0.00291	CcSEcCtD
Pentobarbital—Nausea—Bicalutamide—prostate cancer	0.000294	0.00291	CcSEcCtD
Pentobarbital—Loss of consciousness—Estradiol—prostate cancer	0.000294	0.00291	CcSEcCtD
Pentobarbital—Constipation—Conjugated Estrogens—prostate cancer	0.000291	0.00288	CcSEcCtD
Pentobarbital—Anxiety—Estradiol—prostate cancer	0.000283	0.00281	CcSEcCtD
Pentobarbital—Feeling abnormal—Goserelin—prostate cancer	0.000283	0.00281	CcSEcCtD
Pentobarbital—Dizziness—Ethinyl Estradiol—prostate cancer	0.000276	0.00274	CcSEcCtD
Pentobarbital—Confusional state—Estradiol—prostate cancer	0.000275	0.00272	CcSEcCtD
Pentobarbital—Phenobarbital—CYP1B1—prostate cancer	0.000272	0.119	CrCbGaD
Pentobarbital—Body temperature increased—Goserelin—prostate cancer	0.000272	0.00269	CcSEcCtD
Pentobarbital—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000269	0.00267	CcSEcCtD
Pentobarbital—Shock—Estradiol—prostate cancer	0.000268	0.00266	CcSEcCtD
Pentobarbital—Vomiting—Ethinyl Estradiol—prostate cancer	0.000266	0.00263	CcSEcCtD
Pentobarbital—Anxiety—Mitoxantrone—prostate cancer	0.000264	0.00261	CcSEcCtD
Pentobarbital—Rash—Ethinyl Estradiol—prostate cancer	0.000263	0.00261	CcSEcCtD
Pentobarbital—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000263	0.00261	CcSEcCtD
Pentobarbital—Headache—Ethinyl Estradiol—prostate cancer	0.000262	0.00259	CcSEcCtD
Pentobarbital—Confusional state—Mitoxantrone—prostate cancer	0.000256	0.00254	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000255	0.00253	CcSEcCtD
Pentobarbital—Hypersensitivity—Goserelin—prostate cancer	0.000253	0.00251	CcSEcCtD
Pentobarbital—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000251	0.00248	CcSEcCtD
Pentobarbital—Shock—Mitoxantrone—prostate cancer	0.00025	0.00247	CcSEcCtD
Pentobarbital—Nausea—Ethinyl Estradiol—prostate cancer	0.000248	0.00246	CcSEcCtD
Pentobarbital—Bradycardia—Capecitabine—prostate cancer	0.000244	0.00241	CcSEcCtD
Pentobarbital—Somnolence—Estradiol—prostate cancer	0.000242	0.0024	CcSEcCtD
Pentobarbital—Thiopental—CYP2E1—prostate cancer	0.00024	0.105	CrCbGaD
Pentobarbital—Hypotension—Mitoxantrone—prostate cancer	0.000237	0.00235	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000236	0.00234	CcSEcCtD
Pentobarbital—Constipation—Estradiol—prostate cancer	0.000233	0.00231	CcSEcCtD
Pentobarbital—Loss of consciousness—Etoposide—prostate cancer	0.000228	0.00225	CcSEcCtD
Pentobarbital—Dizziness—Goserelin—prostate cancer	0.000227	0.00225	CcSEcCtD
Pentobarbital—Ataxia—Epirubicin—prostate cancer	0.000227	0.00224	CcSEcCtD
Pentobarbital—Somnolence—Mitoxantrone—prostate cancer	0.000226	0.00224	CcSEcCtD
Pentobarbital—Dizziness—Conjugated Estrogens—prostate cancer	0.000225	0.00223	CcSEcCtD
Pentobarbital—Feeling abnormal—Estradiol—prostate cancer	0.000225	0.00222	CcSEcCtD
Pentobarbital—Vomiting—Goserelin—prostate cancer	0.000219	0.00217	CcSEcCtD
Pentobarbital—Constipation—Mitoxantrone—prostate cancer	0.000217	0.00215	CcSEcCtD
Pentobarbital—Bradycardia—Prednisone—prostate cancer	0.000217	0.00215	CcSEcCtD
Pentobarbital—Rash—Goserelin—prostate cancer	0.000217	0.00215	CcSEcCtD
Pentobarbital—Phenobarbital—CYP3A5—prostate cancer	0.000217	0.0947	CrCbGaD
Pentobarbital—Dermatitis—Goserelin—prostate cancer	0.000217	0.00214	CcSEcCtD
Pentobarbital—Vomiting—Conjugated Estrogens—prostate cancer	0.000217	0.00214	CcSEcCtD
Pentobarbital—Body temperature increased—Estradiol—prostate cancer	0.000216	0.00213	CcSEcCtD
Pentobarbital—Headache—Goserelin—prostate cancer	0.000215	0.00213	CcSEcCtD
Pentobarbital—Rash—Conjugated Estrogens—prostate cancer	0.000215	0.00213	CcSEcCtD
Pentobarbital—Dermatitis—Conjugated Estrogens—prostate cancer	0.000215	0.00212	CcSEcCtD
Pentobarbital—Headache—Conjugated Estrogens—prostate cancer	0.000213	0.00211	CcSEcCtD
Pentobarbital—Confusional state—Etoposide—prostate cancer	0.000213	0.00211	CcSEcCtD
Pentobarbital—Hallucination—Prednisone—prostate cancer	0.000212	0.0021	CcSEcCtD
Pentobarbital—Phenobarbital—CYP2A6—prostate cancer	0.00021	0.0917	CrCbGaD
Pentobarbital—Ataxia—Doxorubicin—prostate cancer	0.00021	0.00208	CcSEcCtD
Pentobarbital—Feeling abnormal—Mitoxantrone—prostate cancer	0.000209	0.00207	CcSEcCtD
Pentobarbital—Nausea—Goserelin—prostate cancer	0.000204	0.00202	CcSEcCtD
Pentobarbital—Nausea—Conjugated Estrogens—prostate cancer	0.000202	0.002	CcSEcCtD
Pentobarbital—Hypersensitivity—Estradiol—prostate cancer	0.000201	0.00199	CcSEcCtD
Pentobarbital—Body temperature increased—Mitoxantrone—prostate cancer	0.000201	0.00199	CcSEcCtD
Pentobarbital—Hypotension—Etoposide—prostate cancer	0.000197	0.00195	CcSEcCtD
Pentobarbital—Syncope—Docetaxel—prostate cancer	0.000193	0.00191	CcSEcCtD
Pentobarbital—Loss of consciousness—Docetaxel—prostate cancer	0.000189	0.00187	CcSEcCtD
Pentobarbital—Somnolence—Etoposide—prostate cancer	0.000188	0.00186	CcSEcCtD
Pentobarbital—Hypersensitivity—Mitoxantrone—prostate cancer	0.000187	0.00185	CcSEcCtD
Pentobarbital—Syncope—Capecitabine—prostate cancer	0.000187	0.00185	CcSEcCtD
Pentobarbital—Loss of consciousness—Capecitabine—prostate cancer	0.000183	0.00181	CcSEcCtD
Pentobarbital—Constipation—Etoposide—prostate cancer	0.000181	0.00179	CcSEcCtD
Pentobarbital—Dizziness—Estradiol—prostate cancer	0.00018	0.00179	CcSEcCtD
Pentobarbital—Confusional state—Docetaxel—prostate cancer	0.000177	0.00175	CcSEcCtD
Pentobarbital—Anxiety—Capecitabine—prostate cancer	0.000177	0.00175	CcSEcCtD
Pentobarbital—Feeling abnormal—Etoposide—prostate cancer	0.000174	0.00172	CcSEcCtD
Pentobarbital—Vomiting—Estradiol—prostate cancer	0.000173	0.00172	CcSEcCtD
Pentobarbital—Shock—Docetaxel—prostate cancer	0.000173	0.00171	CcSEcCtD
Pentobarbital—Rash—Estradiol—prostate cancer	0.000172	0.0017	CcSEcCtD
Pentobarbital—Dermatitis—Estradiol—prostate cancer	0.000172	0.0017	CcSEcCtD
Pentobarbital—Confusional state—Capecitabine—prostate cancer	0.000171	0.0017	CcSEcCtD
Pentobarbital—Headache—Estradiol—prostate cancer	0.000171	0.00169	CcSEcCtD
Pentobarbital—Agitation—Prednisone—prostate cancer	0.000171	0.00169	CcSEcCtD
Pentobarbital—Bradycardia—Epirubicin—prostate cancer	0.00017	0.00168	CcSEcCtD
Pentobarbital—Angioedema—Prednisone—prostate cancer	0.00017	0.00168	CcSEcCtD
Pentobarbital—Shock—Capecitabine—prostate cancer	0.000167	0.00166	CcSEcCtD
Pentobarbital—Body temperature increased—Etoposide—prostate cancer	0.000167	0.00165	CcSEcCtD
Pentobarbital—Syncope—Prednisone—prostate cancer	0.000166	0.00165	CcSEcCtD
Pentobarbital—Hypotension—Docetaxel—prostate cancer	0.000164	0.00162	CcSEcCtD
Pentobarbital—Loss of consciousness—Prednisone—prostate cancer	0.000163	0.00161	CcSEcCtD
Pentobarbital—Nausea—Estradiol—prostate cancer	0.000162	0.0016	CcSEcCtD
Pentobarbital—Vomiting—Mitoxantrone—prostate cancer	0.000162	0.0016	CcSEcCtD
Pentobarbital—Rash—Mitoxantrone—prostate cancer	0.00016	0.00159	CcSEcCtD
Pentobarbital—Dermatitis—Mitoxantrone—prostate cancer	0.00016	0.00158	CcSEcCtD
Pentobarbital—Headache—Mitoxantrone—prostate cancer	0.000159	0.00158	CcSEcCtD
Pentobarbital—Hypotension—Capecitabine—prostate cancer	0.000159	0.00157	CcSEcCtD
Pentobarbital—Anxiety—Prednisone—prostate cancer	0.000157	0.00156	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—prostate cancer	0.000157	0.00155	CcSEcCtD
Pentobarbital—Somnolence—Docetaxel—prostate cancer	0.000156	0.00155	CcSEcCtD
Pentobarbital—Hypersensitivity—Etoposide—prostate cancer	0.000156	0.00154	CcSEcCtD
Pentobarbital—Thiopental—CYP3A4—prostate cancer	0.000151	0.0659	CrCbGaD
Pentobarbital—Nausea—Mitoxantrone—prostate cancer	0.000151	0.00149	CcSEcCtD
Pentobarbital—Constipation—Docetaxel—prostate cancer	0.00015	0.00149	CcSEcCtD
Pentobarbital—Shock—Prednisone—prostate cancer	0.000149	0.00148	CcSEcCtD
Pentobarbital—Phenobarbital—CYP2E1—prostate cancer	0.000149	0.0651	CrCbGaD
Pentobarbital—Phenobarbital—CYP2C19—prostate cancer	0.000148	0.0645	CrCbGaD
Pentobarbital—Phenobarbital—CYP1A1—prostate cancer	0.000147	0.0642	CrCbGaD
Pentobarbital—Constipation—Capecitabine—prostate cancer	0.000145	0.00144	CcSEcCtD
Pentobarbital—Feeling abnormal—Docetaxel—prostate cancer	0.000145	0.00143	CcSEcCtD
Pentobarbital—Tension—Epirubicin—prostate cancer	0.000142	0.00141	CcSEcCtD
Pentobarbital—Nervousness—Epirubicin—prostate cancer	0.000141	0.0014	CcSEcCtD
Pentobarbital—Feeling abnormal—Capecitabine—prostate cancer	0.00014	0.00139	CcSEcCtD
Pentobarbital—Dizziness—Etoposide—prostate cancer	0.00014	0.00138	CcSEcCtD
Pentobarbital—Body temperature increased—Docetaxel—prostate cancer	0.000139	0.00137	CcSEcCtD
Pentobarbital—Body temperature increased—Capecitabine—prostate cancer	0.000134	0.00133	CcSEcCtD
Pentobarbital—Vomiting—Etoposide—prostate cancer	0.000134	0.00133	CcSEcCtD
Pentobarbital—Agitation—Epirubicin—prostate cancer	0.000133	0.00132	CcSEcCtD
Pentobarbital—Rash—Etoposide—prostate cancer	0.000133	0.00132	CcSEcCtD
Pentobarbital—Dermatitis—Etoposide—prostate cancer	0.000133	0.00132	CcSEcCtD
Pentobarbital—Headache—Etoposide—prostate cancer	0.000132	0.00131	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—prostate cancer	0.000132	0.0013	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—prostate cancer	0.00013	0.00129	CcSEcCtD
Pentobarbital—Syncope—Epirubicin—prostate cancer	0.00013	0.00129	CcSEcCtD
Pentobarbital—Constipation—Prednisone—prostate cancer	0.00013	0.00128	CcSEcCtD
Pentobarbital—Hypersensitivity—Docetaxel—prostate cancer	0.000129	0.00128	CcSEcCtD
Pentobarbital—Loss of consciousness—Epirubicin—prostate cancer	0.000128	0.00126	CcSEcCtD
Pentobarbital—Nausea—Etoposide—prostate cancer	0.000126	0.00124	CcSEcCtD
Pentobarbital—Hypersensitivity—Capecitabine—prostate cancer	0.000125	0.00124	CcSEcCtD
Pentobarbital—Feeling abnormal—Prednisone—prostate cancer	0.000125	0.00124	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—prostate cancer	0.000123	0.00122	CcSEcCtD
Pentobarbital—Anxiety—Epirubicin—prostate cancer	0.000123	0.00122	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—prostate cancer	0.00012	0.00119	CcSEcCtD
Pentobarbital—Body temperature increased—Prednisone—prostate cancer	0.00012	0.00119	CcSEcCtD
Pentobarbital—Confusional state—Epirubicin—prostate cancer	0.000119	0.00118	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—prostate cancer	0.000118	0.00117	CcSEcCtD
Pentobarbital—Shock—Epirubicin—prostate cancer	0.000117	0.00115	CcSEcCtD
Pentobarbital—Dizziness—Docetaxel—prostate cancer	0.000116	0.00115	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—prostate cancer	0.000114	0.00113	CcSEcCtD
Pentobarbital—Dizziness—Capecitabine—prostate cancer	0.000112	0.00111	CcSEcCtD
Pentobarbital—Vomiting—Docetaxel—prostate cancer	0.000112	0.00111	CcSEcCtD
Pentobarbital—Hypersensitivity—Prednisone—prostate cancer	0.000112	0.0011	CcSEcCtD
Pentobarbital—Rash—Docetaxel—prostate cancer	0.000111	0.0011	CcSEcCtD
Pentobarbital—Hypotension—Epirubicin—prostate cancer	0.000111	0.0011	CcSEcCtD
Pentobarbital—Dermatitis—Docetaxel—prostate cancer	0.000111	0.0011	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—prostate cancer	0.000111	0.00109	CcSEcCtD
Pentobarbital—Headache—Docetaxel—prostate cancer	0.00011	0.00109	CcSEcCtD
Pentobarbital—Vomiting—Capecitabine—prostate cancer	0.000108	0.00107	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—prostate cancer	0.000108	0.00107	CcSEcCtD
Pentobarbital—Rash—Capecitabine—prostate cancer	0.000107	0.00106	CcSEcCtD
Pentobarbital—Dermatitis—Capecitabine—prostate cancer	0.000107	0.00106	CcSEcCtD
Pentobarbital—Headache—Capecitabine—prostate cancer	0.000107	0.00105	CcSEcCtD
Pentobarbital—Somnolence—Epirubicin—prostate cancer	0.000105	0.00104	CcSEcCtD
Pentobarbital—Nausea—Docetaxel—prostate cancer	0.000104	0.00103	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—prostate cancer	0.000102	0.00101	CcSEcCtD
Pentobarbital—Constipation—Epirubicin—prostate cancer	0.000101	0.001	CcSEcCtD
Pentobarbital—Nausea—Capecitabine—prostate cancer	0.000101	0.001	CcSEcCtD
Pentobarbital—Dizziness—Prednisone—prostate cancer	0.0001	0.000992	CcSEcCtD
Pentobarbital—Feeling abnormal—Epirubicin—prostate cancer	9.76e-05	0.000966	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—prostate cancer	9.74e-05	0.000965	CcSEcCtD
Pentobarbital—Vomiting—Prednisone—prostate cancer	9.63e-05	0.000953	CcSEcCtD
Pentobarbital—Rash—Prednisone—prostate cancer	9.55e-05	0.000945	CcSEcCtD
Pentobarbital—Dermatitis—Prednisone—prostate cancer	9.54e-05	0.000945	CcSEcCtD
Pentobarbital—Headache—Prednisone—prostate cancer	9.49e-05	0.000939	CcSEcCtD
Pentobarbital—Phenobarbital—CYP3A4—prostate cancer	9.38e-05	0.041	CrCbGaD
Pentobarbital—Constipation—Doxorubicin—prostate cancer	9.37e-05	0.000928	CcSEcCtD
Pentobarbital—Body temperature increased—Epirubicin—prostate cancer	9.36e-05	0.000927	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—prostate cancer	9.03e-05	0.000894	CcSEcCtD
Pentobarbital—Nausea—Prednisone—prostate cancer	9e-05	0.000891	CcSEcCtD
Pentobarbital—Hypersensitivity—Epirubicin—prostate cancer	8.73e-05	0.000864	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—prostate cancer	8.66e-05	0.000858	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—prostate cancer	8.07e-05	0.000799	CcSEcCtD
Pentobarbital—Dizziness—Epirubicin—prostate cancer	7.83e-05	0.000776	CcSEcCtD
Pentobarbital—Vomiting—Epirubicin—prostate cancer	7.53e-05	0.000746	CcSEcCtD
Pentobarbital—Rash—Epirubicin—prostate cancer	7.47e-05	0.000739	CcSEcCtD
Pentobarbital—Dermatitis—Epirubicin—prostate cancer	7.46e-05	0.000739	CcSEcCtD
Pentobarbital—Headache—Epirubicin—prostate cancer	7.42e-05	0.000735	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—prostate cancer	7.25e-05	0.000718	CcSEcCtD
Pentobarbital—Nausea—Epirubicin—prostate cancer	7.04e-05	0.000697	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—prostate cancer	6.97e-05	0.00069	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—prostate cancer	6.91e-05	0.000684	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—prostate cancer	6.9e-05	0.000684	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—prostate cancer	6.87e-05	0.00068	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—prostate cancer	6.51e-05	0.000645	CcSEcCtD
Pentobarbital—CYP3A4—Metabolism—HAO1—prostate cancer	1.12e-05	0.000114	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.12e-05	0.000114	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.12e-05	0.000114	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PLCB2—prostate cancer	1.09e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LRP2—prostate cancer	1.09e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2C18—prostate cancer	1.09e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.09e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HPGD—prostate cancer	1.07e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—B4GALT4—prostate cancer	1.07e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—P4HB—prostate cancer	1.07e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC22A1—prostate cancer	1.04e-05	0.000106	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SULT2A1—prostate cancer	1.01e-05	0.000103	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TNFRSF21—prostate cancer	1.01e-05	0.000103	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MED12—prostate cancer	9.95e-06	0.000101	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GNG5—prostate cancer	9.87e-06	0.000101	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTAP—prostate cancer	9.82e-06	0.0001	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP7B1—prostate cancer	9.82e-06	0.0001	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.78e-06	9.95e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	9.6e-06	9.77e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SULT1E1—prostate cancer	9.57e-06	9.75e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SRD5A1—prostate cancer	9.57e-06	9.75e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOA3—prostate cancer	9.51e-06	9.68e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	9.3e-06	9.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PSAT1—prostate cancer	9.17e-06	9.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TST—prostate cancer	9.17e-06	9.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CSAD—prostate cancer	9.17e-06	9.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ADI1—prostate cancer	9.17e-06	9.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GRHL1—prostate cancer	9.17e-06	9.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CBR1—prostate cancer	9.17e-06	9.33e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	9.16e-06	9.32e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSD17B3—prostate cancer	9.13e-06	9.3e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ACSL4—prostate cancer	9.13e-06	9.3e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HPGDS—prostate cancer	9.07e-06	9.24e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	9.03e-06	9.19e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2C19—prostate cancer	9.02e-06	9.18e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ACHE—prostate cancer	8.8e-06	8.96e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTT1—prostate cancer	8.8e-06	8.96e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PHGDH—prostate cancer	8.75e-06	8.91e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ARG2—prostate cancer	8.75e-06	8.91e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—UMPS—prostate cancer	8.75e-06	8.91e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	8.71e-06	8.87e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LDHB—prostate cancer	8.59e-06	8.74e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UGT2B17—prostate cancer	8.52e-06	8.68e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CKMT2—prostate cancer	8.52e-06	8.68e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GRHPR—prostate cancer	8.52e-06	8.68e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UGT2B15—prostate cancer	8.52e-06	8.68e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKR1C3—prostate cancer	8.46e-06	8.62e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP3A5—prostate cancer	8.43e-06	8.58e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PRKACB—prostate cancer	8.42e-06	8.57e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP17A1—prostate cancer	8.33e-06	8.48e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PDHA1—prostate cancer	8.14e-06	8.29e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—UCP3—prostate cancer	8.14e-06	8.29e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA3—prostate cancer	8.14e-06	8.29e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TCN2—prostate cancer	8.14e-06	8.29e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PGAM2—prostate cancer	8.01e-06	8.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AOX1—prostate cancer	8.01e-06	8.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NAGLU—prostate cancer	8.01e-06	8.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—RFK—prostate cancer	8.01e-06	8.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM3—prostate cancer	8.01e-06	8.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MBTPS1—prostate cancer	8.01e-06	8.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SULT2B1—prostate cancer	8.01e-06	8.16e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOA2—prostate cancer	7.94e-06	8.08e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSD3B1—prostate cancer	7.76e-06	7.9e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC22A3—prostate cancer	7.76e-06	7.9e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NAT1—prostate cancer	7.6e-06	7.73e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SRD5A2—prostate cancer	7.6e-06	7.73e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AMACR—prostate cancer	7.6e-06	7.73e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—DEGS1—prostate cancer	7.6e-06	7.73e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP3A43—prostate cancer	7.6e-06	7.73e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC5A5—prostate cancer	7.57e-06	7.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.53e-06	7.67e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA4—prostate cancer	7.44e-06	7.58e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TBXAS1—prostate cancer	7.44e-06	7.58e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2E1—prostate cancer	7.4e-06	7.53e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NQO1—prostate cancer	7.31e-06	7.45e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.28e-06	7.41e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA2—prostate cancer	7.25e-06	7.39e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSD17B1—prostate cancer	7.25e-06	7.38e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TH—prostate cancer	7.21e-06	7.34e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SULT1A1—prostate cancer	7.17e-06	7.3e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCG5—prostate cancer	7.17e-06	7.3e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP3A4—prostate cancer	7.13e-06	7.26e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1B1—prostate cancer	7.01e-06	7.14e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA1—prostate cancer	7e-06	7.13e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSD3B2—prostate cancer	6.92e-06	7.05e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NAT2—prostate cancer	6.92e-06	7.05e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTO1—prostate cancer	6.92e-06	7.05e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GGT1—prostate cancer	6.79e-06	6.91e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOA1—prostate cancer	6.69e-06	6.81e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.65e-06	6.77e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PLCB2—prostate cancer	6.63e-06	6.75e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LRP2—prostate cancer	6.63e-06	6.75e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2C18—prostate cancer	6.63e-06	6.75e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP19A1—prostate cancer	6.59e-06	6.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—P4HB—prostate cancer	6.51e-06	6.62e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HPGD—prostate cancer	6.46e-06	6.57e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.46e-06	6.57e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—RXRA—prostate cancer	6.36e-06	6.48e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC22A1—prostate cancer	6.33e-06	6.44e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.26e-06	6.37e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SULT2A1—prostate cancer	6.17e-06	6.28e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—COMT—prostate cancer	6.13e-06	6.24e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTP1—prostate cancer	6.1e-06	6.21e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6.07e-06	6.18e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MED12—prostate cancer	6.07e-06	6.18e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GNG5—prostate cancer	6.02e-06	6.13e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ITPR1—prostate cancer	6e-06	6.11e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.91e-06	6.01e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTAP—prostate cancer	5.91e-06	6.01e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA3—prostate cancer	5.8e-06	5.9e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.76e-06	5.86e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.76e-06	5.86e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.7e-06	5.8e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TYMS—prostate cancer	5.67e-06	5.77e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—prostate cancer	5.61e-06	5.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HPGDS—prostate cancer	5.53e-06	5.63e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LPL—prostate cancer	5.5e-06	5.6e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ACSL4—prostate cancer	5.49e-06	5.59e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.49e-06	5.59e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTT1—prostate cancer	5.37e-06	5.46e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ACHE—prostate cancer	5.37e-06	5.46e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1A1—prostate cancer	5.31e-06	5.41e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2A6—prostate cancer	5.3e-06	5.4e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.28e-06	5.38e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ERCC2—prostate cancer	5.27e-06	5.37e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PHGDH—prostate cancer	5.26e-06	5.36e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UMPS—prostate cancer	5.26e-06	5.36e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ARG2—prostate cancer	5.26e-06	5.36e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LDHB—prostate cancer	5.16e-06	5.26e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKR1C3—prostate cancer	5.16e-06	5.25e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PRKACB—prostate cancer	5.13e-06	5.23e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP17A1—prostate cancer	5.08e-06	5.17e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.07e-06	5.16e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.01e-06	5.1e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—prostate cancer	4.95e-06	5.04e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PDHA1—prostate cancer	4.89e-06	4.98e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UCP3—prostate cancer	4.89e-06	4.98e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TCN2—prostate cancer	4.89e-06	4.98e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA3—prostate cancer	4.89e-06	4.98e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPARA—prostate cancer	4.86e-06	4.95e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA2—prostate cancer	4.84e-06	4.93e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.67e-06	4.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.67e-06	4.75e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.62e-06	4.7e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CAV1—prostate cancer	4.57e-06	4.65e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2E1—prostate cancer	4.51e-06	4.59e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA4—prostate cancer	4.48e-06	4.56e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.48e-06	4.56e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NQO1—prostate cancer	4.46e-06	4.54e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TH—prostate cancer	4.4e-06	4.47e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.37e-06	4.45e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA2—prostate cancer	4.36e-06	4.44e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP3A4—prostate cancer	4.35e-06	4.43e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.33e-06	4.41e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.31e-06	4.39e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCG5—prostate cancer	4.31e-06	4.39e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1B1—prostate cancer	4.28e-06	4.35e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA1—prostate cancer	4.21e-06	4.28e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CG—prostate cancer	4.16e-06	4.24e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.16e-06	4.24e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTO1—prostate cancer	4.16e-06	4.24e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NAT2—prostate cancer	4.16e-06	4.24e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GGT1—prostate cancer	4.14e-06	4.22e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA1—prostate cancer	4.08e-06	4.15e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.02e-06	4.09e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PLCB2—prostate cancer	3.99e-06	4.06e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LRP2—prostate cancer	3.99e-06	4.06e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.99e-06	4.06e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—INS—prostate cancer	3.94e-06	4.01e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—P4HB—prostate cancer	3.91e-06	3.98e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—RXRA—prostate cancer	3.88e-06	3.95e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CREBBP—prostate cancer	3.86e-06	3.93e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.81e-06	3.88e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.77e-06	3.84e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—COMT—prostate cancer	3.74e-06	3.8e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTP1—prostate cancer	3.72e-06	3.79e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.71e-06	3.78e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ITPR1—prostate cancer	3.66e-06	3.73e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CD—prostate cancer	3.66e-06	3.73e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MED12—prostate cancer	3.65e-06	3.72e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GNG5—prostate cancer	3.62e-06	3.69e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.6e-06	3.66e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA3—prostate cancer	3.49e-06	3.55e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TYMS—prostate cancer	3.46e-06	3.52e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NOS3—prostate cancer	3.46e-06	3.52e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—prostate cancer	3.42e-06	3.48e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LPL—prostate cancer	3.35e-06	3.42e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HPGDS—prostate cancer	3.33e-06	3.39e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.31e-06	3.37e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.24e-06	3.3e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ACHE—prostate cancer	3.23e-06	3.29e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTT1—prostate cancer	3.23e-06	3.29e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ERCC2—prostate cancer	3.21e-06	3.27e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CB—prostate cancer	3.19e-06	3.25e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.19e-06	3.25e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS2—prostate cancer	3.16e-06	3.22e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.1e-06	3.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PRKACB—prostate cancer	3.09e-06	3.14e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.05e-06	3.11e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—prostate cancer	3.02e-06	3.08e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPARA—prostate cancer	2.96e-06	3.02e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA2—prostate cancer	2.91e-06	2.96e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CAV1—prostate cancer	2.79e-06	2.84e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.78e-06	2.83e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTEN—prostate cancer	2.76e-06	2.81e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.71e-06	2.76e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NQO1—prostate cancer	2.68e-06	2.73e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.66e-06	2.71e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TH—prostate cancer	2.64e-06	2.69e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—EP300—prostate cancer	2.63e-06	2.68e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.57e-06	2.62e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.54e-06	2.58e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GGT1—prostate cancer	2.49e-06	2.54e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA1—prostate cancer	2.45e-06	2.5e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.42e-06	2.46e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—INS—prostate cancer	2.4e-06	2.45e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CREBBP—prostate cancer	2.35e-06	2.4e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—RXRA—prostate cancer	2.33e-06	2.38e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—COMT—prostate cancer	2.25e-06	2.29e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTP1—prostate cancer	2.24e-06	2.28e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.23e-06	2.27e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ITPR1—prostate cancer	2.2e-06	2.24e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NOS3—prostate cancer	2.11e-06	2.14e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TYMS—prostate cancer	2.08e-06	2.12e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—prostate cancer	2.06e-06	2.09e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LPL—prostate cancer	2.02e-06	2.05e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.95e-06	1.98e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.94e-06	1.98e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.94e-06	1.98e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ERCC2—prostate cancer	1.93e-06	1.97e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS2—prostate cancer	1.93e-06	1.96e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—prostate cancer	1.82e-06	1.85e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPARA—prostate cancer	1.78e-06	1.81e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTEN—prostate cancer	1.68e-06	1.71e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CAV1—prostate cancer	1.68e-06	1.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—EP300—prostate cancer	1.6e-06	1.63e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKT1—prostate cancer	1.59e-06	1.62e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.53e-06	1.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—INS—prostate cancer	1.44e-06	1.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CREBBP—prostate cancer	1.41e-06	1.44e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.34e-06	1.37e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NOS3—prostate cancer	1.27e-06	1.29e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.21e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.17e-06	1.19e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS2—prostate cancer	1.16e-06	1.18e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTEN—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKT1—prostate cancer	9.68e-07	9.86e-06	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—EP300—prostate cancer	9.64e-07	9.81e-06	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.13e-07	7.26e-06	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKT1—prostate cancer	5.82e-07	5.93e-06	CbGpPWpGaD
